Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
Condition(s):Opioid-use DisorderLast Updated:March 15, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Opioid-use DisorderLast Updated:March 15, 2022Recruiting
Condition(s):Opioid-use DisorderLast Updated:March 24, 2020Withdrawn
Condition(s):Neonatal Abstinence Syndrome; Neonatal Opiate Withdrawal SyndromeLast Updated:February 11, 2022Completed
Condition(s):Opioid-use DisorderLast Updated:March 9, 2021Completed
Condition(s):Opioid Use DisorderLast Updated:October 14, 2020Withdrawn
Condition(s):Neonatal Abstinence SyndromeLast Updated:September 26, 2017Completed
Condition(s):Opioid-use DisorderLast Updated:April 15, 2021Completed
Condition(s):Knee OsteoarthritisLast Updated:May 13, 2019Unknown status
Condition(s):Opioid-Use Disorder; Opioid OverdoseLast Updated:March 2, 2022Not yet recruiting
Condition(s):Other Acute Postoperative Pain; Prolonged Endotracheal IntubationLast Updated:February 4, 2016Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.